Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis
Authors:
- Maja MockenhauptMMMaja Mockenhaupt
- Jan-Nico Bouwes-BavinckJBJan-Nico Bouwes-Bavinck
- Luigi NaldiLNLuigi Naldi
- Jean-Claude RoujeauJRJean-Claude Roujeau
- 1 September 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (14) , 1843-1848
Abstract
Objective To draw attention to the many cases of Stevens–Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) related to nevirapine detected in a multinational case–control study of SJS and TEN. Methods Actively detected cases and matched hospital controls were interviewed for exposure to drugs and other risk factors. Data were analysed with case–control and case-crossover methods. Results Between May 1997 and November 1999, a diagnosis of SJS or TEN was established in 246 patients. Eighteen were known to be infected by HIV-1 (7.3%), 15 out of these 18 had been exposed to nevirapine. The reaction began 10–240 days after the introduction of nevirapine (median, 12 days) and all patients had received escalating doses. In 10 patients the reaction occurred with the initial dosage. All but one patients received simultaneously a variety of other antiretroviral agents but no specific drug combination emerged, and nevirapine was the only drug significantly associated with an increased risk of SJS or TEN in HIV-infected persons [odds ratio, 62 (10.4; +∞) in the case–control analysis; odds ratio, +∞ (2.8; +∞) in the case-crossover analysis]. Conclusions In European countries the risk of SJS or TEN in the context of HIV infection appears to be associated with nevirapine. The respect of a lead-in period does not appear to prevent SJS or TEN. Because of the severity of these reactions and the long elimination half-life of nevirapine, we suggest discontinuation of the drug as soon as any eruption occurs.Keywords
This publication has 15 references indexed in Scilit:
- Association between Cellular-Telephone Calls and Motor Vehicle CollisionsNew England Journal of Medicine, 1997
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in GermanyArchives of Dermatology, 1993
- Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiformeArchives of Dermatology, 1993
- Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patientsAIDS, 1993
- Clinical and Laboratory Markers of Hypersensitivity to Trimethoprim-Sulfamethoxazole in Patients with Pneumocystis carinii Pneumonia and AIDSThe Journal of Infectious Diseases, 1993
- Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosisThe Lancet, 1991
- The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute EventsAmerican Journal of Epidemiology, 1991
- Median Unbiased Estimation for Binary DataThe American Statistician, 1989
- Algorithm AS 36: Exact Confidence Limits for the Odds Ratio in a 2 × 2 TableJournal of the Royal Statistical Society Series C: Applied Statistics, 1971